Toxicity of two North American Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms

Clinical Toxicology

Volumn 45, Issue 6, 2007, Pages 678-687

  De Roodt, Adolfo Rafael ^a,d   Estevez Ramírez, Judith ^b   Litwin, Silvana ^a   Magaña, Penélope ^b   Olvera, Alejandro ^c   Alagón, Alejandro ^c  

^a Ministerio de Salud Y Ambiente ^*  (Argentina)

^b Instituto Bioclon SA de CV   (Mexico)

^c INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

^d Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

Author keywords

Antivenom; Immunology; Loxosceles; Neutralization; Spiders; Therapeutics; Toxicity; Venom

Indexed keywords

SPIDER VENOM; SPIDER VENOM ANTISERUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DRUG MECHANISM; ENVENOMATION; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; RABBIT; SERODIAGNOSIS; SKIN NECROSIS; SPIDER;

ANIMALS; ANTIVENINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; LETHAL DOSE 50; MICE; MICE, INBRED STRAINS; NECROSIS; NEUTRALIZATION TESTS; NORTH AMERICA; PHOSPHORIC DIESTER HYDROLASES; RABBITS; SKIN; SPIDER VENOMS; SPIDERS;

ARANEAE; LOXOSCELES; LOXOSCELES BONETI; LOXOSCELES GAUCHO; LOXOSCELES LAETA; LOXOSCELES RECLUSA; MUS; ORYCTOLAGUS CUNICULUS;

EID: 34548612048     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650701397001     Document Type: Article

References (58)

1. Buchler W. Spiders. In: Buchler W, Buckley E, eds. Venomous animals and their Venoms. Vol. III Venomous Invertebrates. New York: Academic Press, 1971:197-277.
2. Isbister GK, White J. Clinical consequences of spider bites: Recent advances in our understanding. Toxicon 2004; 43:477-492.
3. Ministerio de Saúde. Fundacaó Nacional de Saúde. In: Manual de Diagnóstico e Tratamento de Acidentes por Animais Peçonhentos. Ministerio de Saúde, Fundação Nacional de Saúde, Brasilia, 1999:57-61.
4. Zavaleta Martínez-Vargas A. Loxoscelismo, un problema de salud en el Perú. Bol Of Sanit Panam 1987; 103:378-386.
5. White J, Cardoso JL, Fan HW. Clinical Toxicology of spiders' bites. In: Meier J, White J, eds. Clinical Toxicology of Animal Venoms and Poisons. Boca Raton, FL: CRS Press, 1995:261-329.
6. da Silva PH, da Silveira RB, Appel MH, Mangili OC, Gremski W, Veiga SS. Brown spiders and Loxoscelism. Toxicon 2004; 44:693-709.
7. Siqueira Franca FO. Accidents by Loxosceles. Mem Inst Butantan 1990; 52:63-64.
8. Babcock JL, Civello DJ, Geren CR. Purification and characterization of a toxin from brown recluse spider (Loxosceles reclusa) venom gland extracts. Toxicon 1981; 19:677-689.
9. Smith CW, Micks DW. A comparative study of the venom and other components of three species of Loxosceles. Am J Trop Med Hyg 1968; 17:651-656.
10. Siqueira Franca FO, Barbaro KC, Abdulkader RCRM. Rhabdomyolisis in presumed viscerocutaneous loxocelism: report of two cases. Pirenopolis, Brazil: VII Simposio da Sociedade Brasileira de Toxinologia, 2002:130.
11. de Roodt AR, Salomón OD, Lloveras S, Orduna TA. Poisoning by Loxosceles spiders in Argentina. Medicina (Buenos Aires) 2001; 62:83-94.
12. Tambourgi DV, Magnoli FC, Von Eickstedt VR, Benedetti ZC, Petricevich VL, da Silva WD. Incorporation of a 35-kilodalton purified protein from Loxosceles intermedia spider venom transforms human erythrocytes into activators of autologous complement alternative pathway. J Immunol 1995; 155:4459-4466.
13. Tambourgi DV, Magnoli FC, van den Berg CW, Morgan BP, de Araujo PS, Alves EW, Da Silva WD. Sphingomyelinases in the venom of the spider Loxosceles intermedia are responsible for both dermonecrosis and complement-dependent hemolysis. Biochem Biophys Res Commun 1998; 251:366-373.
14. Tambourgi DV, Morgan BP, de Andrade MRG, Magnoli FC, van den Berg C. Loxosceles intermedia spider envenomation induces activation of an endogenous metalloproteinase resulting in cleavage of glycophorins from the erythrocyte surface and facilitating complement-mediated lysis. Blood 2000; 95:683-691.
15. Tambourgi DV, Petrievich VL, Magnoli FC, Assaf SL, Jancar S, Dias Da Silva W. Endotoxemic-like shock induced by Loxosceles spider venoms: Pathological changes and putative cytokine mediators. Toxicon 1998; 36:391-403.
16. Barbaro KC, Costa Cardoso JL. Mecanismo de Acao do Veneno de Loxosceles e Aspectos Clínicos do Loxoscelismo. In: Costa Cardoso JL, De Siquiera Franca FO, Wen FH, Santana Málaque CM, Hadad V Jr, eds. Animais Peconhentos no Brasil. Biología, Clínica e Terapéutica dos Accidentes. Sao Paulo: Sarvier-FAPESP, 2003:160-174.
17. Barbaro KC, von Eickstedt VRD, Mota I. Antigenic cross-reactivity of venoms from medically important Loxosceles (Aranae) species in Brazil. Toxicon 1994; 32:687-693.
18. Barbaro KC, Ferreira ML, Cardoso DF, von Eickstedt VRD, Mota I. Identification and neutralization of biological activities in the venoms of Loxosceles spiders. Braz J Med Biol Res 1996; 29:1491-1497.
19. Escalante-Galindo P, Montoya-Cabrera MA, Terroba-Larios VM, Nava-Juarez AR, Escalante-Flores I. Local dermonecrotic loxoscelism in children bitten by the spider Loxosceles reclusa (the "violin" spider). Gac Med Mex. 1999; 135:423-426.
20. Sams HH, Hearth SB, Long LL, Wilson DC, Sanders DH, King LE Jr. Nineteen documented cases of Loxosceles reclusa envenomation. J Am Acad Dermatol 2001; 44:603-608.
21. Vetter RS, Barger DK. An infestation of 2,055 brown recluse spiders (Araneae: Sicariidae) and no envenomations in a Kansas home: implications for bite diagnoses in non endemic areas. J Med Entomol 2002; 39:948-951.
22. Wilson DC, King LE Jr. Spiders and spider bites. Dermatol Clin 1990; 8:277-286.
23. Gertsch WJ, Ennik F. The spider Genus Loxosceles in North America, Central America and the West Indies (Araneae, Loxoscelidae). Bulletin of the American Museum of Natural History 1983; 175:264-360.
24. Ramos-Cerrillo B, Olvera A, Odell GV, Zamudio F, Paniagua-Solis J, Alagon A, Stock RP. Genetic and enzymatic characterization of sphingomyelinase D isoforms from the North American fiddleback spiders Loxosceles boneti and Loxosceles reclusa. Toxicon 2004; 44:507-514.
25. Sánchez-Villegas M del C, López de Silanes J. Use of a recombinant antivenoms for local loxoscelism. Acta Toxicológica Argentina 2005; 13 (suppl.):11-12.
26. Isbister GK, Graudins A, White J, Warrell, D. Antivenom treatment in arachnidism. J Toxicol Clin Toxicol 2003; 41:291-300.
27. Babcok JL, Suber RL, Frith CH, Geren CR. Systemic effect in mice of venom apparatus extract and toxin from the brown recluse spider (Loxosceles reclusa). Toxicon 1981; 19:463-471.
28. Geren CR, Chan TK, Howell DR, Odell GV. Isolation and characterization of toxins from brown recluse spider venom (Loxosceles reclusa). Archives of Biochemistry and Biophysics 1976; 174:90-99.
29. Bradford MM. A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
30. Laemmli UK. Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 1970; 227:680-685.
31. Comission of Life Sciences. Guía para el Cuidado y Uso de los Animales de Laboratorio. Lomelí C. ed. Mexican Academy of Sciences, Mexico, 2002.
32. 50 e titulacáo do antiveneno em camundongos. Mem Inst Butantan 1983/84; 47/48:45-53.
33. World Health Organization. Progress in the Characterization of Venoms and Standarization of Antivenoms. Geneva: Offset Publication, WHO, 1981:23-24.
34. Theakston RDG, Reid HA. Development of simple standard assay procedures for the characterization of snake venoms. Bulletin of the World Health Organization 1983; 61:949-956.
35. Christensen PA. The preparation and purification of antivenin. Memorias do Instituto Butantan 1966; 22:245-250.
36. Theakston RDG, Lloyd-Jones MJ, Reid HA. Micro-ELISA for detecting and assaying snake venom and venom-antibody. Lancet 1977; 24:639-641.
37. Siles Villarroel MS, Zelante F, Furlanetto RS, Rolim Rosa R. Contribucao ao estudo imunoquímico de venenos botrópicos III. Analise dos componentes antigénicos comuns a traves da dupla difusao e imunoelectroforese en gel de agar. Mem Inst Butantan 1976/77; 40/41:241-250.
38. de Roodt AR, Litwin S, Dokmetjian JC, Vidal JC. A reduced immunization scheme to obtain an experimental anti-Loxosceles laeta ("violinist spider") venom. J Natural Toxins 2002; 11:193-203.
39. de Roodt AR, Gould I, Manzanelli VM. Corporal measures of Loxosceles laeta and Kukulcania (Filistata) sp. from the province of Buenos Aires. Acta Toxicológica Argentina 2005; 13 (suppl.):117-118.
40. Gómez HF, Miller MJ, Waggener MW, Lankford HA, Warren JS. Antigenic cross-reactivity of venoms from medically important North American Loxosceles spider species. Toxicon 2001; 39:817-824.
41. Estévez J, Dolab JA, Ramos-Cerrillo B, Olvera A, Paniagua-Solis JF, Magaña P, Litwin S, Salas M, Zavaleta A, Alagón A, de Roodt AR. Toxicity and Immunological Reactivity of Two North American Loxosceles ("Brown Spider") venoms. VIII Congresso da Sociedade Brasileira de Toxinologia / VIII Symposium of the Pan American Section of the International Society on Toxinology, Angras dos Reis, 2004:19-23.
42. Barbaro KC. Biological, immunochemical and biochemical characterization of venoms of spiders of the genus Loxosceles. Thesis. J Venom Anim Toxins 1997; 3:53.
43. Barbaro KC, Knysak I, Martins R, Hogan C, Winkel K. Enzymatic characterization, antigenic cross reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas. Toxicon 2005; 45:489-499.
44. Tambourgi DV, Pedrosa MM, Van Den Berg CW, Goncalves-De-Andrade RM, Ferracini M, Paixao-Cavalcante D, Morgan BP, Rushmere NK. Molecular cloning, expression, function and immunoreactivities of members of a gene family of sphingomyelinases from Loxosceles venom glands. Mol Immunol 2004; 41:831-40.
45. de Oliveira KC, Goncalvez de Andrade RM, Piazza RM, Ferreira JM, van den Berg CW, Tambourgi DV. Variations in Loxosceles spider venom composition and toxicity contribute to the severity of envenomation. Toxicon 2005; 45:421-429.
46. th Annual Scientific Meeting of the Australasian College of Tropical Medicine, Cairns, Australia, 2002:142.
47. Bravo M, Oviedo I, Farias P, Schenone H. Study of anti-loxosceles serum action on hemolytic and ulcero-necrotic cutaneous effects of Loxosceles laeta venom. Rev Med Chil. 1994; 122:625-629.
48. Schenone H, Saavedra T, Rojas A, Villarroel F. Loxoscelismo en Chile. Estudios epidemiológicos, clínicos y experimentales. Rev Inst Med Trop Sao Paulo 1989; 31: 403-415.
49. Martino O, Mathet H, Masini RD, Ibarra Grasso A, Thompson R, Gondell C, Bosch J. Emponzoñamiento humano provocado por venenos de origen animal. Secretaría de Salud de la República Argentina, 1979:19-67.
50. Martino O, Orduna T. Patología cutánea ponzoñosa e infecciosa provocada por agresiones de animales. Centro Municipal de Patologías Regionales Argentinas (CEMPRA), Buenos Aires, 1995.
51. Torres JB, Marques M, Nicolella A, Severo Kluwe LH. Loxosceles. In: Nicolella A, Barros E, Torres JB, Marques M. Hospital de Clínicas de Porto Alegre, eds. Acidentes com Animais Peçonhentos. Consulta rápida. Porto Alegre, 1997:127-129.
52. Zavaleta-Martínez Vargas A, Salas-Arruz M. Suero Antiloxoscélico Monovalente Heterólogo (Equino). In: Zavaleta-Martínez Vargas A, Salas-Arruz M, Cabezas-Sánchez C, Chang-Neyra J, Carrillo-Parodi C. Farmacología de venenos y antivenenos de serpiente. Ministerio de Salud, Instituto Nacional de Salud Serie de Documentos No 6, Lima, 1998:117-121.
53. Sanabria H, Zavaleta A. Panorama epidemiológico del Loxoscelismo en el Perú. Revista de Medicina Experimental 1997; 14:33-40.
54. Gómez HF, Miller MJ, Warren JS. Intradermal anti-Loxosceles Fab fragments attenuate dermonecrotic arachnidism. Acad Emerg Med 1999; 6:107-114.
55. Guilherme P, Fernandes I, Barbaro KC. Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies. Toxicon 2001; 39:1333-1342.
56. Braz A, Minozzo J, Abreu JC, Gubert IC, Chávez-Olórtegui C. Development and evaluation of the neutralizing capacity of horse antivenom against the Brazilian spider Loxosceles intermedia. Toxicon 1999; 37:1323-1328.
57. Grisolía CA, Stanchi NO, Francini F, Castro ES. Actividad de los Centros Antiponzoñosos. Primeros 20 años: 1975-1994. Provincia de Buenos Aires, Ministerio de Salud, 1996:33-37.
58. Ramos-Cerrillo BM. Producción, evaluación y caracterización de los inmunógenos recombinantes de las esfingomielinasas de L. boneti, L. reclusa y L. laeta. Master in Science Degree Thesis, Institute of Biotechnology, Autonomous University of Mexico, 2005.